Progressive intermittent claudication is associated with impaired fibrinolysis. (Q50891002)

24 March 2018

title

Progressive intermittent claudication is associated with impaired fibrinolysis. (English)

1 reference

24 March 2018

intermittent claudication

main subject

1 reference

1 reference

Killewich LA

1

1 reference

24 March 2018

Gardner AW

2

1 reference

24 March 2018

Macko RF

3

1 reference

24 March 2018

Hanna DJ

4

1 reference

24 March 2018

Goldberg AP

5

1 reference

24 March 2018

Cox DK

6

1 reference

24 March 2018

Flinn WR

7

1 reference

24 March 2018

publication date

1 April 1998

1 reference

24 March 2018

Journal of Vascular Surgery

published in

1 reference

24 March 2018

volume

27

1 reference

24 March 2018

issue

4

1 reference

24 March 2018

page(s)

645-650

1 reference

24 March 2018

Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2898%2970229-0

7 January 2021

Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2898%2970229-0

7 January 2021

Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2898%2970229-0

7 January 2021

The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2898%2970229-0

7 January 2021

Fibrinogen and risk of cardiovascular disease. The Framingham Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2898%2970229-0

7 January 2021

Fibrinogen is a predictor of mortality in coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2898%2970229-0

7 January 2021

Tissue plasminogen activator and other risk factors as predictors of cardiovascular events in patients with severe angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2898%2970229-0

7 January 2021

Fibrinolytic Variables and Cardiovascular Prognosisin Patients With Stable Angina Pectoris Treated With Verapamil or Metoprolol

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2898%2970229-0

7 January 2021

Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2898%2970229-0

7 January 2021

Evaluation of the coagulation and fibrinolytic systems in men with intermittent claudication

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2898%2970229-0

7 January 2021

Coagulation system activation and increase of D-dimer levels in peripheral arterial occlusive disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2898%2970229-0

7 January 2021

Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study. The PLAT Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2898%2970229-0

7 January 2021

Serum lipoproteins and hemostatic function in intermittent claudication

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2898%2970229-0

7 January 2021

The clinical utility of a six-minute walk test in peripheral arterial occlusive disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2898%2970229-0

7 January 2021

Guidelines for peripheral percutaneous transluminal angioplasty of the abdominal aorta and lower extremity vessels. A statement for health professionals from a special writing group of the Councils on Cardiovascular Radiology, Arteriosclerosis, Card

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2898%2970229-0

7 January 2021

Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1)

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2898%2970229-0

7 January 2021

Fibrinolytic response during exercise and epinephrine infusion in the same subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2898%2970229-0

7 January 2021

The occurrence of angiographically detected intracoronary thrombus in patients with unstable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2898%2970229-0

7 January 2021

Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2898%2970229-0

7 January 2021

Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2898%2970229-0

7 January 2021

Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2898%2970229-0

7 January 2021

Clearance of tissue plasminogen activator (TPA) and TPA/plasminogen activator inhibitor type 1 (PAI-1) complex: relationship to elevated TPA antigen in patients with high PAI-1 activity levels

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2898%2970229-0

7 January 2021

Effects of physical conditioning on fibrinolytic variables and fibrinogen in young and old healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2898%2970229-0

7 January 2021

Influence of a rehabilitation sports programme on the fibrinolytic activity of patients after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2898%2970229-0

7 January 2021

10.1016/S0741-5214(98)70229-0

Identifiers

DOI

1 reference

24 March 2018

1 reference

24 March 2018